Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
6
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
6
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
fda
pfizer
bristol-myers squibb
clinical trials
ipo
moderna
abbvie
astrazeneca
cancer immunotherapy
deals
What
bio
roundup
life
science
companies
ipo
medical
week
annual
approved
arena’s
becker
billions
biopharma
biotechs
bounty
breast
cancer
cancer's
car
celgene
chose
cig
clinical
close
colleagues
comeback
company
conference
corner
data
deals
delivered
device
digital
disease
dollars
drug
eaton
epidemic
Language
Current search:
merck
×
celgene
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way